Funder: National Institutes of Health
Due Date: November 7, 2018
The purpose of this funding opportunity announcement (FOA) is to invite applications to stimulate innovative collaborative research in the NCATS’ Clinical and Translational Science Award (CTSA) consortium.
PAR-15-173 encourages X02 pre-applications for the CTSA Innovation Award Program. X02 applications will be evaluated by outside experts, and applicants whose X02 pre-applications are found to be meritorious and programmatically relevant will be notified of the opportunity to submit a full application in response to this U01 FOA.